According to Santé Publique France, in 2022, cancer was the leading cause of death in France, accounting for 25.5% of deaths, despite significant improvements in therapeutic management over recent decades.
In addition to antitumor therapy, care includes a nutritional and physical activity approach aimed at maintaining patients’ quality of life and well-being, as well as preventing cancer-related muscle mass loss.
The devices developed by Aminogram provide a fast, simple, non-invasive, and accurate method for assessing health risks and measuring the impact of interventions based on body composition data. In less than 10 seconds, the analysis allows to:
With the devices developed by Aminogram, provide personalized and precise monitoring for improved care of patients with cancer.
Do you have an Aminogram project, a question, or a need? Don’t hesitate to contact us by filling out this form.
© 2025 Aminogram Trademark – All rights reserved.
Fill out the form below and we’ll get back to you as soon as possible.
Remplissez le formulaire ci-dessous et nous vous contacterons dans les plus brefs délais.